{
    "@context": "http://id.who.int/icd/contexts/contextForICD10Entity.json",
    "@id": "http://id.who.int/icd/release/10/2019/D68.3",
    "parent": [
        "http://id.who.int/icd/release/10/2019/D68"
    ],
    "browserUrl": "http://apps.who.int/classifications/icd10/browse/2019/en#/D68.3",
    "code": "D68.3",
    "title": {
        "@language": "en",
        "@value": "Haemorrhagic disorder due to circulating anticoagulants"
    },
    "inclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "Haemorrhage during long-term use of anticoagulants"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Hyperheparinaemia"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Increase in: antithrombin"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Increase in: anti-VIIIa"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Increase in: anti-IXa"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Increase in: anti-Xa"
            }
        },
        {
            "label": {
                "@language": "en",
                "@value": "Increase in: anti-XIa"
            }
        }
    ],
    "exclusion": [
        {
            "label": {
                "@language": "en",
                "@value": "long-term use of anticoagulants without haemorrhage"
            }
        }
    ],
    "codingHint": [
        {
            "label": {
                "@language": "en",
                "@value": "Use additional external cause code (Chapter XX), if desired, to identify any administered anticoagulant."
            }
        }
    ],
    "classKind": "category"
}